Search

Your search keyword '"Noventa, Franco"' showing total 16 results
Start Over Author "Noventa, Franco" Journal journal of hepatology
16 results on '"Noventa, Franco"'

1. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Author

Degasperi, Elisabetta, Spinetti, Angiola, Lombardi, Andrea, Landonio, Simona, Rossi, Maria Cristina, Pasulo, Luisa, Pozzoni, Pietro, Giorgini, Alessia, Fabris, Paolo, Romano, Antonietta, Lomonaco, Lorenzo, Puoti, Massimo, Vinci, Maria, Gatti, Federico, Carolo, Giada, Zoncada, Alessia, Bonfanti, Paolo, Russo, Francesco Paolo, Aghemo, Alessio, Soria, Alessandro, Centenaro, Riccardo, Maggiolo, Franco, Rovere, Pierangelo, Pasin, Francesca, Paon, Veronica, Faggiano, Giovanni, Vario, Alessandro, Grossi, Glenda, Soffredini, Roberta, Carriero, Canio, Paolucci, Stefania, Noventa, Franco, Alberti, Alfredo, Lampertico, Pietro, and Fagiuoli, Stefano

Published
2019
Full Text
View/download PDF

2. Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

Author

D'Ambrosio, Roberta, Pasulo, Luisa, Puoti, Massimo, Vinci, Maria, Schiavini, Monica, Lazzaroni, Sergio, Soria, Alessandro, Gatti, Federico, Menzaghi, Barbara, Aghemo, Alessio, Capelli, Francesca, Rumi, Maria Grazia, Morini, Lorenzo, Giorgini, Alessia, Pigozzi, Marie Graciella, Rossini, Angelo, Maggiolo, Franco, Pan, Angelo, Memoli, Massimo, Spinelli, Ombretta, Del Poggio, Paolo, Saladino, Valeria, Spinetti, Angiola, De Bona, Anna, Capretti, Andrea, Uberti-Foppa, Caterina, Bonfanti, Paolo, Terreni, Natalia, Menozzi, Fernanda, Colombo, Alberto Eraldo, Giglio, Omar, Centenaro, Riccardo, Borghi, Marta, Baiguera, Chiara, Picciotto, Viviana, Landonio, Simona, Gori, Andrea, Magnani, Carlo, Noventa, Franco, Paolucci, Stefania, Lampertico, Pietro, and Fagiuoli, Stefano

Published
2019
Full Text
View/download PDF

3. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

Author

Romano, Antonietta, Angeli, Paolo, Piovesan, Sara, Noventa, Franco, Anastassopoulos, Georgios, Chemello, Liliana, Cavalletto, Luisa, Gambato, Martina, Russo, Francesco Paolo, Burra, Patrizia, Vincenzi, Valter, Scotton, Pier Giorgio, Panese, Sandro, Tempesta, Diego, Bertin, Tosca, Carrara, Maurizio, Carlotto, Antonio, Capra, Franco, Carolo, Giada, Scroccaro, Giovanna, and Alberti, Alfredo

Published
2018
Full Text
View/download PDF

6. Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy

Author

Fabris, Paolo, primary, Noventa, Franco, additional, Fagiuoli, Stefano, additional, Farina, Francesca, additional, Carolo, Giada, additional, Carlotto, Antonio, additional, Rovere, Pierangelo, additional, Cavinato, Silvia, additional, Romano, Antonietta, additional, Vario, Alessandro, additional, Franceschet, Irene, additional, Panese, sandro, additional, Bertin, Tosca, additional, Zappalà, Francesco, additional, Alberti, Alfredo, additional, Lobello, Salvatore, additional, Aghemo, Alessio, additional, Bruno, Raffaele, additional, Puoti, Massimo, additional, Rizzardini, Giuliano, additional, Spinelli, Ombretta, additional, Pigozzi, Marie Graciella, additional, Spinetti, Angiola, additional, Menzaghi, Barbara, additional, Pan, Angelo, additional, Bella, Daniele, additional, Re, Tiziana, additional, Borghi, Marta, additional, Lombardi, Andrea, additional, Viganò, Mauro, additional, Salpietro, Stefania, additional, Lleo, Ana, additional, and Del Punta, Veronica, additional

Published
2020
Full Text
View/download PDF

7. THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients

Author

Gambato, Martina, primary, Spinetti, Angiola, additional, Pasulo, Luisa, additional, D’ambrosio, Roberta, additional, Puoti, Massimo, additional, Schiavini, Monica, additional, Fabris, Paolo, additional, Sacchi, Paolo, additional, Gulminetti, Roberto, additional, Carolo, Giada, additional, Scotton, Piergiorgio, additional, Pozzan, Caterina, additional, Vinci, Maria, additional, Viganò, Mauro, additional, Lobello, Salvatore, additional, Zuin, Massimo Giovanni, additional, Aghemo, Alessio, additional, Rumi, Maria Grazia, additional, Carrara, Maurizio, additional, Manfrin, Vinicio, additional, Uberti-Foppa, Caterina, additional, Panese, Sandro, additional, Cattelan, Francesca, additional, Paon, Veronica, additional, Pan, Angelo, additional, Spinelli, Ombretta, additional, Monforte, Antonella d'Arminio, additional, Colli, Agostino, additional, Spinzi, Giancarlo, additional, Russo, Francesco Paolo, additional, Chemello, Liliana, additional, Vincenzi, Valter, additional, Grossi, Paolo Antonio, additional, Buscarini, Elisabetta, additional, Cardaci, Giovanna, additional, Soria, Alessandro, additional, Menzaghi, Barbara, additional, Mendeni, Monia, additional, Degasperi, Elisabetta, additional, Soffredini, Roberta, additional, Colpani, Maria, additional, Comi, Laura, additional, Zuccaro, Valentina, additional, Zaltron, Serena, additional, Gori, ANDREA, additional, Poggio, Paolo Del, additional, Giorgini, Alessia, additional, Capretti, Andrea, additional, Memoli, massimo, additional, Pigozzi, Marie Graciella, additional, Rossi, Maria Cristina, additional, Cavalletto, Luisa, additional, Capra, Franco, additional, Colombo, Alberto, additional, Dibenedetto, Clara, additional, Landonio, Simona, additional, Noventa, Franco, additional, Lampertico, Pietro, additional, Castelli, Francesco, additional, Alberti, Alfredo, additional, and Fagiuoli, Stefano, additional

Published
2019
Full Text
View/download PDF

8. THU-128-Renal safety in 3,264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

Author

D’ambrosio, Roberta, primary, Pasulo, Luisa, additional, Giorgini, Alessia, additional, Spinetti, Angiola, additional, Uberti-Foppa, Caterina, additional, Fanetti, Ilaria, additional, Puoti, Massimo, additional, Aghemo, Alessio, additional, Viganò, Paolo, additional, Vinci, Maria, additional, Menzaghi, Barbara, additional, Lombardi, Andrea, additional, Pan, Angelo, additional, Pigozzi, Marie Graciella, additional, Grossi, Paolo Antonio, additional, Lazzaroni, Sergio, additional, Spinelli, Ombretta, additional, Invernizzi, Pietro, additional, Maggiolo, Franco, additional, Colli, Agostino, additional, Molteni, Chiara, additional, Terreni, Natalia, additional, Monforte, Antonella d’Arminio, additional, Poggio, Paolo Del, additional, Taddei, Maria Teresa, additional, Colombo, Silvia, additional, Brocchieri, Alessandra, additional, Bhoori, Sherrie, additional, Buscarini, Elisabetta, additional, Centenaro, Riccardo, additional, Mendeni, Monia, additional, Colombo, Alberto, additional, Marco, Mariella Di, additional, Dionigi, Elena, additional, Bella, Daniele, additional, Borghi, Marta, additional, Zuin, Massimo Giovanni, additional, Zaltron, Serena, additional, Noventa, Franco, additional, Lampertico, Pietro, additional, and Fagiuoli, Stefano, additional

Published
2019
Full Text
View/download PDF

9. SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy

Author

Russo, Francesco Paolo, primary, Gambato, Martina, additional, Piovesan, Sara, additional, Romano, Antonietta, additional, Lobello, Salvatore, additional, Panese, sandro, additional, Paon, Veronica, additional, Tosca, Bertin, additional, Vincenzi, Valter, additional, Franceschet, Irene, additional, Pozzan, Caterina, additional, Angeli, Paolo, additional, Chemello, Liliana, additional, Noventa, Franco, additional, Carolo, Giada, additional, Cattelan, Annamaria, additional, Burra, Patrizia, additional, and Alberti, Alfredo, additional

Published
2019
Full Text
View/download PDF

10. THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy

Author

Pasulo, Luisa, primary, Gambato, Martina, additional, Spinetti, Angiola, additional, D’ambrosio, Roberta, additional, Puoti, Massimo, additional, Ciancio, Alessia, additional, Marco, Vito Di, additional, Calvaruso, Vincenza, additional, Piero, Colombatto, additional, Brunetto, Maurizia, additional, Schiavini, Monica, additional, Sacchi, Paolo, additional, Gulminetti, Roberto, additional, Carolo, Giada, additional, Scotton, Piergiorgio, additional, Pozzan, Caterina, additional, Vinci, Maria, additional, Vigano, Mauro, additional, Lombardi, Andrea, additional, Lobello, Salvatore, additional, Zuin, Massimo Giovanni, additional, Aghemo, Alessio, additional, Rumi, Maria Grazia, additional, Manfrin, Vinicio, additional, Uberti-Foppa, Caterina, additional, Panese, Sandro, additional, Paon, Veronica, additional, Pan, Angelo, additional, Spinelli, Ombretta, additional, Monforte, Antonella d’Arminio, additional, Colli, Agostino, additional, Spinzi, Giancarlo, additional, Russo, Francesco Paolo, additional, Chemello, Liliana, additional, Vincenzi, Valter, additional, Grossi, Paolo Antonio, additional, Buscarini, Elisabetta, additional, Soria, Alessandro, additional, Menzaghi, Barbara, additional, Mendeni, Monia, additional, Soffredini, Roberta, additional, Colpani, Maria, additional, Zaltron, Serena, additional, Gori, ANDREA, additional, Giorgini, Alessia, additional, Cologni, Giuliana, additional, Cartabellotta, Fabio, additional, Difrancesco, Lorenzo, additional, Cacciola, Irene, additional, Albanese, Antonio, additional, Rosolini, Maria Antonietta Di, additional, Giacomo, Antonio Di, additional, Capretti, Andrea, additional, Memoli, massimo, additional, Cavalletto, Luisa, additional, Capra, Franco, additional, Colombo, Alberto, additional, Dibenedetto, Clara, additional, Magni, Carlo Federico, additional, Noventa, Franco, additional, Lampertico, Pietro, additional, Castelli, Francesco, additional, Alberti, Alfredo, additional, and Fagiuoli, Stefano, additional

Published
2019
Full Text
View/download PDF

11. THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks

Author

Degasperi, Elisabetta, primary, Spinetti, Angiola, additional, Lombardi, Andrea, additional, Landonio, Simona, additional, Scotton, Pier Giorgio, additional, Pasulo, Luisa, additional, Carlotto, Antonio, additional, Giorgini, Alessia, additional, Pozzoni, Pietro, additional, Angeli, Paolo, additional, Carrara, Maurizio, additional, Puoti, Massimo, additional, Gatti, Federico, additional, Carolo, Giada, additional, Vinci, Maria, additional, Zoncada, Alessia, additional, Bonfanti, Paolo, additional, Aghemo, Alessio, additional, Soria, Alessandro, additional, Centenaro, Riccardo, additional, Maggiolo, Franco, additional, Russo, Francesco Paolo, additional, Rovere, Pierangelo, additional, Piovesan, Sara, additional, Capra, Franco, additional, Viviani, Filippo, additional, Morini, Lorenzo, additional, Soffredini, Roberta, additional, Carriero, Canio, additional, Paolucci, Stefania, additional, Noventa, Franco, additional, Alberti, Alfredo, additional, Lampertico, Pietro, additional, and Fagiuoli, Stefano, additional

Published
2019
Full Text
View/download PDF

12. THU-180-Treatment of genotype 3 HCV infection in the large real-life “Navigatore Lombardia” multicentre cohort: Results from three different regimens

Author

Soria, Alessandro, primary, Lapadula, Giuseppe, additional, Colella, Elisa, additional, Gambaro, Alessandra, additional, Spolti, Anna, additional, Bottalico, Nunzia, additional, Pasulo, Luisa, additional, Carderi, Isabella, additional, Lazzaroni, Sergio, additional, Boldizzoni, Roberto, additional, Scabeni, Luciana, additional, Poggio, Paolo Del, additional, Mels, Guido Colloredo, additional, Marco, Mariella Di, additional, Colombo, Alberto, additional, Grasso, Valentina, additional, Spinelli, Ombretta, additional, Pigozzi, Marie Graciella, additional, Graffeo, Massimo, additional, Spinetti, Angiola, additional, Carriero, Canio, additional, Menzaghi, Barbara, additional, Terreni, Natalia, additional, Brambilla, Paola, additional, Pan, Angelo, additional, Bella, Daniele, additional, Liani, Cecilia, additional, Polo, Silvia, additional, Aimo, Gianpiero, additional, Bhoori, Sherrie, additional, Bonfanti, Paolo, additional, Molteni, Chiara, additional, Gatti, Federico, additional, Viganò, Paolo, additional, Dionigi, Elena, additional, Centenaro, Riccardo, additional, Vinci, Maria, additional, Puoti, Massimo, additional, Borghi, Marta, additional, D’ambrosio, Roberta, additional, Degasperi, Elisabetta, additional, Soffredini, Roberta, additional, Valenti, Luca, additional, Gulminetti, Roberto, additional, Lombardi, Andrea, additional, Schiavini, Monica, additional, Landonio, Simona, additional, Rizzardini, Giuliano, additional, Capretti, Andrea, additional, Rumi, Maria Grazia, additional, Viganò, Mauro, additional, Giorgini, Alessia, additional, Merlini, Esther, additional, Bona, Anna De, additional, Monforte, Antonella D’arminio, additional, Uberti-Foppa, Caterina, additional, Hasson, Hamid, additional, Salpietro, Stefania, additional, Grossi, Paolo Antonio, additional, Aghemo, Alessio, additional, Gritti, Sara, additional, Noventa, Franco, additional, Lampertico, Pietro, additional, and Fagiuoli, Stefano, additional

Published
2019
Full Text
View/download PDF

15. FRI401 - Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy

Author

Fabris, Paolo, Noventa, Franco, Fagiuoli, Stefano, Farina, Francesca, Carolo, Giada, Carlotto, Antonio, Rovere, Pierangelo, Cavinato, Silvia, Romano, Antonietta, Vario, Alessandro, Franceschet, Irene, Panese, sandro, Bertin, Tosca, Zappalà, Francesco, Alberti, Alfredo, Lobello, Salvatore, Aghemo, Alessio, Bruno, Raffaele, Puoti, Massimo, Rizzardini, Giuliano, Spinelli, Ombretta, Pigozzi, Marie Graciella, Spinetti, Angiola, Menzaghi, Barbara, Pan, Angelo, Bella, Daniele, Re, Tiziana, Borghi, Marta, Lombardi, Andrea, Viganò, Mauro, Salpietro, Stefania, Lleo, Ana, and Del Punta, Veronica

Published
2020
Full Text
View/download PDF

16. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

Author

Realdi, Giuseppe, Fattovich, Giovanna, Hadziyannis, Stephanos, Schalm, Solko W., Almasio, Piero, Sanchez-Tapias, Josè, Christensen, Erik, Giustina, Giuliano, Noventa, Franco, and (EUROHEP), The Investigators of the European Concerted Action on Viral Hepatitis

Abstract

A multicenter longitudinal study was performed to assess the survival of hepatitis B surface antigen positive compensated cirrhosis, primarily in relation to hepatitis B virus replication and hepatitis delta virus infection, and to construct a prognostic index based on entry characteristics. This cohort study involved nine university medical centers in Europe. Three hundred and sixty-six Caucasian HBsAg positive patients with cirrhosis who had never had clinical manifestations of hepatic decompensation were enrolled and followed for a mean period of 72 months (6 to 202 months). Inclusion criteria were biopsy-proven cirrhosis, information on serum hepatitis B e antigen and antibody to hepatitis D virus at the time of diagnosis and absence of complications of cirrhosis. At entry 35% of the patients were HBeAg positive, 48% of the patients tested were HBV-DNA positive and 20% anti-HDV positive. Death occurred in 84 (23%) patients, mainly due to liver failure (45 cases) or hepatocellular carcinoma (23 cases). The cumulative probability of survival was 84% and 68% at 5 and 10 years, respectively. Cox's regression analysis identified six variables that independently correlated with survival: age, albumin, platelets, splenomegaly, bilirubin and HBeAg positivity at time of diagnosis. According to the contribution of each of these factors to the final model, a prognostic index was constructed that allows calculation of the estimated survival probability. No difference in survival of hepatitis D virus infected and uninfected patients was observed. Termination of hepatitis B virus replication and/or biochemical remission during follow up correlated with a highly significant better survival. These data show that in compensated cirrhosis B, hepatitis B virus replication, age and indirect indicators of poor hepatic reserve and established portal hypertension significantly worsen the clinical course of the disease, whereas hepatitis D virus infection does not influence the prognosis. The highly significant improvement in life expectancy following cessation of hepatitis B virus replication and biochemical remission favors antiviral therapy in those patients with a guarded prognosis, as estimated by a prognostic index.

Published
1994
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results